Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: A study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

Diabetologia

Volumn 54, Issue 12, 2011, Pages 3037-3046

  Grote, V A ^a   Rohrmann, S ^a,b   Nieters, A ^a,c   Dossus, L ^a   Tjonneland A ^d   Halkjaer J ^d   Overvad, K ^e   Fagherazzi, G ^f,g   Boutron Ruault, M C ^f,g   Morois, S ^f,g   Teucher, B ^a   Becker, S ^a,h   Sluik, D ⁱ   Boeing, H ⁱ   Trichopoulou, A ^j,k   Lagiou, P ^j,l,m   Trichopoulos, D ^l,m   Palli, D ⁿ   Pala, V ^o   Tumino, R ^p   Vineis, P ^q,r   Panico, S ^s   Rodriguez L ^t   Duell, E J ^u,v   Molina Montes, E ^v,w   Dorronsoro, M ^v,x   Huerta, J M ^v,y   Ardanaz, E ^v,z   Jeurnink, S M ^aa   Beulens, J W J ^r,aa   Peeters, P H M ^r,aa   Sund, M ^ab   Ye, W ^ab,ac   Lindkvist, B ^ad   Johansen, D ^ae   Khaw, K T ^af   Wareham, N ^ag   Allen, N ^ah   Crowe, F ^ah   Jenab, M ^ai   Romieu, I ^ai   Michaud, D S ^r,aj   Riboli, E ^r   Romaguera, D ^r   Bueno De Mesquita, H B ^aa,ak   Kaaks, R ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^j UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^k HELLENIC HEALTH FOUNDATION   (Greece)

^l HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^m BIOMEDICAL RESEARCH FOUNDATION   (Greece)

ⁿ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^o NATIONAL CANCER INSTITUTE   (Italy)

^p CIVILE M P AREZZO HOSPITAL   (Italy)

^q HuGeF Foundation   (Italy)

^r IMPERIAL COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^t Health and Health Care Services Council   (Spain)

^u CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^v CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^w ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^x BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^y Murcia Regional Health Authority   (Spain)

^z INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^aa UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ab UMEÅ UNIVERSITY   (Sweden)

^ac KAROLINSKA INSTITUTE   (Sweden)

^ad UNIVERSITY OF GOTHENBURG   (Sweden)

^ae LUND UNIVERSITY HOSPITAL   (Sweden)

^af UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ag MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ah UNIVERSITY OF OXFORD   (United Kingdom)

^ai INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^aj BROWN UNIVERSITY   (United States)

^ak NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

more..

Author keywords

C peptide; Cohort study; Diabetes; EPIC; HbA1c; Pancreatic cancer

Indexed keywords

C PEPTIDE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CELL ACTIVITY; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; EUROPE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK;

EID: 82455192294     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2316-0     Document Type: Article

References (27)

1. SM Lynch A Vrieling JH Lubin, et al. 2009 Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium Am J Epidemiol 170 403 413 19561064 10.1093/aje/kwp134
2. A Vrieling HB Bueno-de-Mesquita HC Boshuizen, et al. 2010 Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition Int J Cancer 126 2394 2403 19790196 1:CAS:528:DC%2BC3cXjvFahtbw%3D
3. S Raimondi AB Lowenfels AM Morselli-Labate P Maisonneuve R Pezzilli 2010 Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection Best Pract Res Clin Gastroenterol 24 349 358 20510834 10.1016/j.bpg.2010.02.007
4. JM Genkinger D Spiegelman KE Anderson, et al. 2010 A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk Int J Cancer 129 1708 1717 10.1002/ijc.25794
5. AG Renehan M Tyson M Egger RF Heller M Zwahlen 2008 Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 569 578 18280327 10.1016/S0140-6736(08)60269-X (Pubitemid 351232031)
6. R Huxley A Ansary-Moghaddam A Berrington de González F Barzi M Woodward 2005 Type II diabetes and pancreatic cancer: a meta-analysis of 36 studies Br J Cancer 92 2076 2083 15886696 10.1038/sj.bjc.6602619 1:STN:280:DC%2BD2M3ot1Kjug%3D%3D (Pubitemid 40897433)
7. R Pannala A Basu GM Petersen ST Chari 2009 New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer Lancet Oncol 10 88 95 19111249 10.1016/S1470-2045(08)70337-1
8. XZ Ding DM Fehsenfeld LO Murphy J Permert TE Adrian 2000 Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression Pancreas 21 310 320 11039477 10.1097/00006676-200010000-00014 1:STN:280:DC%2BD3cvovVGitQ%3D%3D
9. WE Fisher LG Boros WJ Schirmer 1996 Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors J Surg Res 63 310 313 8661216 10.1006/jsre.1996.0266 1:CAS:528:DyaK28XksVOms7c%3D (Pubitemid 26197211)
10. Hruban RH, Pitman MB, Klimstra DS (2007) Tumors of the pancreas. Armed Forces Institute of Pathology, Washington, DC
11. D Basso M Plebani P Fogar, et al. 1994 Beta-cell function in pancreatic adenocarcinoma Pancreas 9 332 335 8022755 10.1097/00006676-199405000-00008 1:STN:280:DyaK2c3psVensA%3D%3D (Pubitemid 2064807)
12. SM Gapstur PH Gann W Lowe K Liu L Colangelo A Dyer 2000 Abnormal glucose metabolism and pancreatic cancer mortality JAMA 283 2552 2558 10815119 10.1001/jama.283.19.2552 1:CAS:528:DC%2BD3cXjvVemu78%3D (Pubitemid 30324198)
13. SH Jee H Ohrr JW Sull JE Yun M Ji JM Samet 2005 Fasting serum glucose level and cancer risk in Korean men and women JAMA 293 194 202 15644546 10.1001/jama.293.2.194 1:CAS:528:DC%2BD2MXktVyqsg%3D%3D (Pubitemid 40095870)
14. D Johansen T Stocks H Jonsson, et al. 2010 Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project Cancer Epidemiol Biomarkers Prev 19 2307 2317 20826833 10.1158/1055-9965.EPI-10-0234 1:CAS:528:DC%2BC3cXhtFart73M
15. RZ Stolzenberg-Solomon BI Graubard S Chari, et al. 2005 Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers JAMA 294 2872 2878 16352795 10.1001/jama.294.22.2872 1:CAS:528:DC%2BD2MXhtlWrtb7E (Pubitemid 41785868)
16. DS Michaud B Wolpin E Giovannucci, et al. 2007 Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women Cancer Epidemiol Biomarkers Prev 16 2101 2109 17905943 10.1158/1055-9965.EPI-07-0182 1:CAS:528:DC%2BD2sXhtFGjtb%2FE (Pubitemid 47621187)
17. M Haftenberger PH Lahmann S Panico, et al. 2002 Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) Public Health Nutr 5 1147 1162 12639224 10.1079/PHN2002396 1:STN:280:DC%2BD3s7is1OhsQ%3D%3D (Pubitemid 36313610)
18. E Riboli KJ Hunt N Slimani, et al. 2002 European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection Public Health Nutr 5 1113 1124 12639222 10.1079/PHN2002394 1:STN:280:DC%2BD3s7is1Ohsw%3D%3D (Pubitemid 36313608)
19. ADA 2009 International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 1327 1334 10.2337/dc09-9033
20. XH Zhou Q Qiao B Zethelius, et al. 2010 Diabetes, prediabetes and cancer mortality Diabetologia 53 1867 1876 20490448 10.1007/s00125-010-1796-7 1:CAS:528:DC%2BC3cXpsV2ltro%3D
21. SE Kahn RL Hull KM Utzschneider 2006 Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 840 846 17167471 10.1038/nature05482 1:CAS:528:DC%2BD28XhtlShtrzP (Pubitemid 46024990)
22. DP Guh W Zhang N Bansback Z Amarsi CL Birmingham AH Anis 2009 The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis BMC Public Health 9 88 19320986 10.1186/1471-2458-9-88
23. CL Meinhold A Berrington de Gonzalez D Albanes, et al. 2009 Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers Cancer Causes Control 20 681 690 19083105 10.1007/s10552-008-9281-z
24. NT Nguyen XM Nguyen J Lane P Wang 2011 Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006 Obes Surg 21 351 355 21128002 10.1007/s11695-010-0335-4
25. B Farrow Y Sugiyama A Chen E Uffort W Nealon B Mark Evers 2004 Inflammatory mechanisms contributing to pancreatic cancer development Ann Surg 239 763 769 15166955 10.1097/01.sla.0000128681.76786.07 discussion 769-771 (Pubitemid 38669427)
26. Z Lu Y Li A Takwi, et al. 2011 miR-301a as an NF-kappaB activator in pancreatic cancer cells EMBO J 30 57 67 21113131 10.1038/emboj.2010.296 1:CAS:528:DC%2BC3cXhsVOrsbzJ
27. J Spranger A Kroke M Mohlig, et al. 2003 Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes 52 812 817 12606524 10.2337/diabetes.52.3.812 1:CAS:528:DC%2BD3sXitFajt7k%3D (Pubitemid 36323590)